In a model of diabetic nephropathy, there is increased LOX expression in the glomerular and tubular areas of the nephron.74, 75It is then conceivable that in CKD too, LOX contributes to altered platelet properties, in addition to its effect of tissue fibrosis. Here, LOX is linked to chronic kidney disease.